Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Cellvizio I.V.E. with Confocal Miniprobes

K-Number: K193416 · 2020-02-28

Decision Date2020-02-28
Product CodeOWN
Advisory CommitteeGU
DecisionSubstantially Equivalent

Device Summary

Cellvizio I.V.E. with Confocal Miniprobes is a medical device manufactured by Mauna Kea Technologies. It received FDA 510(k) clearance on 2020-02-28 under approval number K193416. The device is classified under product code OWN. It was reviewed by the GU advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Cellvizio I.V.E. with Confocal Miniprobes?

Cellvizio I.V.E. with Confocal Miniprobes is a medical device that received FDA 510(k) clearance on 2020-02-28. It is manufactured by Mauna Kea Technologies. The 510(k) number is K193416.

When was Cellvizio I.V.E. with Confocal Miniprobes approved by the FDA?

Cellvizio I.V.E. with Confocal Miniprobes received FDA 510(k) clearance on 2020-02-28, under approval number K193416.

What company makes Cellvizio I.V.E. with Confocal Miniprobes?

Cellvizio I.V.E. with Confocal Miniprobes is manufactured by Mauna Kea Technologies.

What is the FDA product code for Cellvizio I.V.E. with Confocal Miniprobes?

The FDA product code for Cellvizio I.V.E. with Confocal Miniprobes is OWN.

Related Clinical Trials

Other Devices by Mauna Kea Technologies

View all 9 devices →

Related Devices (Code: OWN)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.